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Abstract
Background: To evaluate the impact and safety of different surgical techniques for aortic root
replacement (ARR) on early and late morbidity and mortality in septuagenarians undergoing ARR.
Methods: Ninety-five patients (73.8 ± 3.2 years) were operated and divided into three groups
according to the aortic root procedure; MECH-group (n = 51) patients with a mechanical
composite graft, BIO-group (n = 22) patients with a customized biological composite graft, and
REIMPL-group (n = 22) patients with a valve sparing aortic root reimplantation (David I). In 42.1%
(40/95) of these patients the aortic arch was replaced. Follow-up was completed in 95.2% (79/83)
of in-hospital survivors.
Results: Hospital mortality was 12.6% (12/95) in the entire population (MECH. 15.7% (8/51), BIO
19.7% (4/22), REIMPL 0% (0/22); p = 0.004). Two patients died intraoperatively. The most frequent
postoperative complications were prolonged mechanical ventilation ((>48 h) in 16.8% (16/93)
(MECH. 7% (7/51), BIO 36.4% (8/22), REIMPL 4.5% (1/22); p = 0.013) and rethoracotomy for
postoperative bleeding in 12.6% (12/95) (MECH. 12% (6/51), BIO 22.7% (5/22), REIMPL 4.5% (1/
22); p = 0.19). Nineteen late deaths (22.9%) (19/83) (MECH 34.8% (15/43), BIO 16.7% (3/18),
REIMPL 4.5% (1/22); p = 0.012) occurred during a mean follow-up of 41 ± 42 months (MECH 48
± 48 months, BIO 25 ± 37 months, REIMPL 40 ± 28 months, p = 0.028). Postoperative NYHA class
decreased significantly (p = 0.017) and performance status (p = 0.027) increased for the entire
group compared to preoperative values.
Conclusion: Our data indicate that valve sparing aortic root reimplantation is safe and effective in
septuagenarians, and is associated with low early and late morbidity and mortality.
Background
Aortic root replacement has become a generally accepted
treatment modality for a variety of aortic root pathologies.
Basically, two different surgical procedures and their mod-
ifications have been advocated. Composite graft valve
replacement (CVR) of the aortic root applying different
techniques for reimplantation of the coronary ostia, and
different types of valve sparing aortic root replacement
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techniques [1-5]. Although results of these techniques
have been extensively described only limited data from
the literature are available about these surgical techniques
in older patients [6-13]. Furthermore, different techniques
for aortic root replacement in septuagenarians have not
been evaluated yet. Thus, the aim of this study was to eval-
uate the impact and safety of different surgical techniques
for aortic root replacement (ARR) on early and late mor-
bidity and mortality as well as functional status in septua-
genarians undergoing aortic root replacement.
Patients and methods
This study was approved by the institutional review
board; all patients gave written informed consent.
Between 1988 and 2003, 95 patients 70 years of age or
older underwent aortic root replacement at our institu-
tion. Preoperative patient's characteristics are depicted in
Table 1. According to the aortic root procedure the
patients were divided into three groups. MECH-group (n
= 51) patients who received a mechanical composite valve
graft, BIO-group (n = 22) patients who received a custom-
ized biological composite valve graft, and REIMPL-group
(n = 22) patients who received a valve sparing aortic root
reimplantation (David I). Concerning the surgical proce-
dure, the choice between a mechanical and biological
valve graft conduit were on the patient's decision. In
patients with pure aortic insufficiency and macroscopi-
cally normal aortic leaflets the decision to perform valve
sparing aortic root reimplantation was dictated by the sur-
geon's preference.
We obtained clinical data by retrospective review of the
hospital archives and follow-up information was gathered
from direct telephone interview of the patient or a close
relative, and contact with the referring physician. Infec-
tious, thrombembolic and bleeding complications were
recorded as required by the guidelines of the American
Association for Thoracic Surgery/Society of Thoracic Sur-
geons [14]. Furthermore current NYHA-Status and per-
formance status scale (Karnofsky) were requested [15].
Thromboembolism, hemorrhage requiring hospitalisa-
tion, aortic valve re-operations or endocarditis were con-
Table 1: Preoperative patient's characteristics and hemodynamics
Variable 1. MECH-group
n = 51
2. BIO-group
n = 22
3. REIMPL-group
n = 22
All
n = 95
p-value
Age at surgery (years)
mean ± SD 73.1 ± 2.7 75.2 ± 3.8 74.1 ± 3.7 73.8 ± 3.2 0.031
range 70–80 70–82 70–83 70–83
Male, n (%) 29 (56.9) 9 (40.9) 10 (45.5) 48 (51) n.s.
BSA (m2) 1.83 ± 0.21 1.78 ± 0.19 1.84 ± 0.24 1.82 ± 0.21 n.s.
NYHA (mean ± SD) 3.06 ± 0.81 3.0 ± 0.58 2.62 ± 0.74 2.94 ± 0.75 0.007
NYHA ≥ III, n (%) 40 (78.4) 19 (86.4) 15 (68.2) 69 (72.6) 0.031
Redo, n (%) 16 (31.4) 1 (4.5) 0 17 (17.9) 0.001
Endocarditis, n (%) 4 (7.8) 1 (4.5) 0 6 (6.3) n.s.
Ø ascending aorta (mm) 63 ± 13 62 ± 10 65 ± 13
Comorbitities, n (%)
AF 12 (23.5) 7 (31.8) 2 (9.1) 21 (22.1) n.s.
MI 4 (7.8) 3 (18.1) 0 7 (7.3) n.s.
Ventricular arrhythmias 2 (3.9) 0 0 2 (2.1) n.s.
Heart failure history 24 (47.1) 8 (36.4) 4 (18.2) 36 (37.9) n.s.
Systemic hypertension 26 (51) 16 (72.7) 18 (81.2) 60 (63.2) 0.026
Diabetes 5 (9.8) 3 (13.6) 3 (13.6) 11 (11.6) n.s.
Hyperlipidemia 9 (17.6) 9 (40.9) 7 (31.8) 25 (26.3) n.s.
Creatinine ≥ 120 μmol/L 9 (17.6) 7 (31.8) 2 (9.1) 17 (17.9) n.s.
COPD 9 (17.6) 5 (22.7) 2 (9.1) 16 (16.8) n.s.
Stroke 1 (1.9) 3 (13.6) 2 (9.1) 6 (6.3) n.s.
TIA/PRIND 2 (3.9) 1 (4.5) 0 4 (3.1) n.s.
Hemodynamics
LVEF (%) 56.8 ± 11.5 58.6 ± 13.3 60.7 ± 13.8 58.3 ± 12.5 n.s.
LVEDP (mmHG) 17.2 ± 9.4 15.1 ± 6.2 15.7 ± 6.9 16.4 ± 8.2 n.s.
mean PAP (mmHG) 25.6 ± 9.6 26.8 ± 11 21 ± 6 24.8 ± 9.4 n.s.
CI (L×min-1 ×m-2) 2.7 ± 1.5 2.4 ± 0.5 2.7 ± 0.9 2.6 ± 0.9 n.s.
mean RAP (mmHG) 5.9 ± 3.8 7.8 ± 3.3 6.9 ± 3.1 6.7 ± 3.5 n.s.
BSA, body surface area; NYHA, New York Heart Association; AF, Atrial fibrillation; MI, previous myocardial infarction; COPD, chronic obstructive pulmonary 
disease; TIA, transient ischemic attack; PRIND, prolonged reversible ischemic neurological deficit; LVEF, left ventricular ejection fraction; LVEDP, left 
ventricular endiastolic pressure, PAP, pulmonary artery pressure; CI, cardiac index; RAP, right atrial pressure.Journal of Cardiothoracic Surgery 2009, 4:17 http://www.cardiothoracicsurgery.org/content/4/1/17
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sidered to be valve related. Follow-up was complete for
95.2% (79/83) of hospital survivors.
Surgical technique
Standard cardiopulmonary bypass with a membrane oxy-
genator and systemic moderate hypothemia (28°C to
32°C) was used unless otherwise indicated. In cases with
aortic arch aneurysms either moderate hypothermic circu-
latory arrest with cold (15°C) antegrade cerebral per-
fusion or deep hypothermia (16°C to 20°C) with
circulatory arrest was utilized [16]. Antegrade cold potas-
sium crystalloid or blood cardioplegic solution was used
for myocardial protection. The left ventricle was vented
through a transmitral catheter. The decision whether to
perform valve sparing aortic root reimplantation or com-
posite replacement of the aortic root was made intraoper-
atively in patients with pure aortic regurgitation, and
depended on the quality of the aortic valve leaflets as well
as on the surgeon's decision. In patients with aortic steno-
sis or mixed aortic valve pathology either a mechanical or
a biological composite valve graft was implanted. All
patients included in this study receiving a mechanical or
biological composite valve graft (CVG) had a button Ben-
tall operation [4]. Biological conduits were manufactured
by selecting appropriate size valve prosthesis and suturing
a vascular graft to it, yielding a readily usable unit as
described by Galla and co-workers [17]. Patients selected
for valve sparing aortic root replacement were operated
upon the classic David I technique as described previously
[18].
The associated operative procedures as well as operative
data are summarized in Table 2.
Statistical methods
Continuous variables are expressed as mean ± SD. Cate-
goric data are given as total numbers and relative frequen-
cies; continuous data are given as mean ± SD, except
where otherwise stated. Groups were compared by one
way ANOVA. Stepwise logistic regression was used for
multivariate analysis. The Kaplan-Meier survival estimates
were used to analyze long-term survival, and freedom
from valve related complications. Statistical differences in
Kaplan-Meier survival estimates were determined by using
the log-rank test. All data analyses were performed with
SPSS 15.0 for Windows (SPSS, Chicago, IL, USA).
Results
As a result of the surgical policy, there was a consistently
increasing caseload of patient receiving either a biological
composite graft or a valve sparing aortic root reimplanta-
tion over the study period (1988–1992: MECH 12 pts.,
1993–1998: MECH 13 pts., BIO 3 pts., REIMPL 2 pts.,
1998–2003: MECH 26 pts., BIO 19 pts., REIMPL 20 pts.).
Patient's preoperative data are depicted in Table 1. The
patient groups were comparable beside the age, incidence
of previous cardiac surgery and arterial hypertension as
well as NYHA-status. Preoperative hemodynamics did not
show any significant differences between groups. Five
patients that were operated on an emergency basis
received a mechanical conduit.
Intraoperative variables are shown in Table 2. The
REIMPL-group had a significantly longer aortic cross
clamp time compared to the MECH-group and BIO-
group. The most frequent concomitant surgical procedure
was aortic arch replacement (42.1%) and coronary artery
bypass grafting (CABG) (29.5%). However, the BIO-
group had a significantly higher number of aortic arch
replacement performed compared to the MECH-group,
furthermore, the percentage of selective antegrade cerebral
perfusion (SACP) for cerebral protection was significantly
higher in this BIO-group compared to the other patient
groups. SACP is routinely performed in our institution
since 1999.
Table 2: Intraoperative data
Variable 1. MECH-group
n = 51
2. BIO-group
n = 22
3. REIMPL-group
n = 22
All
n = 95
p-value
CPB time (min.) 144 ± 60 178 ± 140 159 ± 27 156 ± 82 n.s.
ACC time (min.) 91 ± 31 107 ± 39 123 ± 18 103 ± 33 <0.001
AA-replacement, n (%) 16 (31.4) 15 (68.2) 9 (40.9) 40 (42.1) 0.014
hemiarch, n (%) 15 (93.8) 15 (100) 7 (77.8) 37 0.018
total arch, n (%) 1 (6.2) 0 2 (22.2) 3 n.s.
CA time (min.) 15.5 ± 5.7 17.1 ± 8 17.7 ± 7.7 16.6 ± 7 n.s.
SACP, n (%) 7 (44.4) 15 (100) 6 (66.7) 28 (70) <0.001
MVS 4 (7.8) 3 (13.6) 0 7 n.s.
CABG, n (%) 11 (21.6) 9 (40.9) 7(31.8) 28 (29.5) n.s.
Intraoperative death, n (%) 2 (3.9) 0 0 2 (2.1) n.s.
CPB, cardio pulmonary bypass; ACC, aortic cross clamp; AA-replacement, aortic arch replacemen; SACP, selective antegrade cerebral perfusion, CA, 
circulatory arrest; MVS, mitral valve surgery, CABG, coronary artery bypass grafting.Journal of Cardiothoracic Surgery 2009, 4:17 http://www.cardiothoracicsurgery.org/content/4/1/17
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Hospital morbidity and mortality
Early postoperative complications are shown in Table 3.
The most frequent complications were postoperative pul-
monary insufficiency requiring prolonged ventilation of
patients and rethoracotomy for bleeding complications,
with no statistical differences between groups. Postopera-
tive pulmonary insufficiency occurred more often in the
BIO-group (36.4%) (p = 0.013). 10 patients died within
30 days, in addition to the two intraoperative death the
overall hospital mortality was 12.6% with a statistical sig-
nificant difference between groups (p = 0.004). The causes
of death are summarized in Table 4. Stepwise logistic
regression revealed a history of preoperative cardiac
decompensation (p = 0.026, OR 3.9 (1.1–14.2 95% CI)),
rethoracotomy (p = 0.001, OR 12.8 (3.1–52.2 95% CI))
and postoperative pneumonia (p = 0.002, OR 8.1 (1–64
95% CI)) as independent predictors for in hospital mor-
tality.
Follow-up morbidity and mortality
The follow-up was 41 ± 42.3 months (1–173 months) for
the entire cohort. The follow-up time showed a significant
difference between groups (MECH-group 49 ± 48
months, BIO-group 25 ± 36.9 months, and REIMPL-
group 40 ± 28 months, p = 0.028). Follow-up revealed 22
late deaths, 6 patients died of cardiac related reason, 3 of
valve related reasons. Thus mean survival for the entire
patient population was 8 ± 1 years and showed significant
difference between groups as depicted in Figure 1 and Fig-
ure 2.
23 hospital survivors had to be readmitted to the hospital,
7 for valve related complications, 2 for cardiac related
complications and 14 for other reasons. During follow-up
3 patients had to be re-operated on, all patients had pros-
thetic valve endocarditis, two of these patients died (free-
dom from re-operation 96.2%).
Postoperative NYHA-Status decreased significantly for the
entire cohort as well as patients in the MECH-group and
BIO-group (Figure 3). The performance status of the entire
group (78 ± 7.5% to 81.1 ± 13.2%, p = 0.017) as well for
the MECH-group (76.5 ± 7.8% to 82.6 ± 12.5%, p =
0.015) and BIO-group (76.4 ± 8.1% to 81.3 ± 14.1%, p =
0.027) slightly increased.
Discussion
In this study we demonstrated that different complex sur-
gical techniques for ARR can be performed with good
results in septuagenarians. Our data indicate that valve
sparing aortic root reimplantation is an excellent alterna-
tive to composite conduits with bioprostheses or mechan-
ical prostheses for septuagenarians with favourable short
and long-term outcome.
Composite valve replacement has become a generally
accepted surgical technique for the treatment of aortic
root pathology with acceptable perioperative mortality
rates and good long-term results [6,8,9,11,12,18-21]. The
mortality rate for ARR with composite valve grafts in
recent publications varies between 0.7% and 11% with a
survival rate from 76% to 91.8% at 5 years and 62% to
76% at 10 years. Furthermore, Urbanski and associates
Table 3: Postoperative data of patients surviving the operation
Variable MECH-group
n = 49
BIO-group
n = 22
REIMPL-group
n = 22
All
n = 95
p-value
ICU stay (days)
mean ± SD 3.8 ± 6.2 3.7 ± 4 3.2 ± 4.7 3.6 ± 5.3 n.s.
range 1–37 1–15 1–23 1–37
artificial ventilation (hours)
mean ± SD 112 ± 187 64 ± 93 45 ± 87.8 79 ± 137 n.s.
range 24–792 12–360 11–160 11–192
blood loss (ml) 1128 ± 914 926 ± 882 833 ± 650 999 ± 839 n.s.
red blood cells (units) 2.5 ± 2.8 3.9 ± 3.5 2.9 ± 2 3.2 ± 3 n.s.
fresh frozen plasma (units) 3 ± 2.1 3.4 ± 1.9 2.7 ± 1.86 3.1 ± 1.9 n.s.
rethoracotomy, n (%) 6 (11.8) 5 (22.7) 1 (4.5) 12 (12.9) n.s.
LCO, n (%) 2 (3.9) 1 (4.5) 0 5 n.s.
MOF, n (%) 3 (5.9) 3 (13.6) 0 6 n.s.
MI, n (%) 0 1 (4.5) 0 1 n.s.
Stroke, n (%) 1 (2) 1 (4.5) 0 3 n.s.
Pneumonia, n (%) 4 (7.8) 0 0 3 n.s.
Sepsis, n (%) 4 (7.8) 1 (4.5) 0 5 n.s
Pulmonary insufficiency, n (%) 7 (13.7) 8 (36.4) 1 (4.5) 16 0.013
Hospital mortality, n (%) 9 (17.6) 3 (13.5) 0 12 (12.6) 0.004
ICU, intensiv care unit; LCO, low cardiac output; MOF, multiorgan failure; MI, myocardial infarction.Journal of Cardiothoracic Surgery 2009, 4:17 http://www.cardiothoracicsurgery.org/content/4/1/17
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showed in a case matched study with 200 patients, that
ARR can be performed with a similar operative risk, valve
related morbidity and late mortality as isolated aortic
valve replacement [21]. However, recent published series
showed that valve sparing aortic root replacement tech-
niques are a valuable option for patients with macroscop-
ically normal leaflets [3,10]. The hospital mortalities in
these studies vary around 3–5%. The functional results
showed freedom from re-operation in 94 – 99% of differ-
ent sub cohorts.
In the vast majority of these studies the patients were
younger. Due to the limited data from the literature there
is still an ongoing debate whether ARR should be per-
formed in elderly patients >70 years due to an anticipated
higher mortality rate for ARR compared to isolated aortic
Table 4: Causes of hospital mortality according to the surgical technique
Cause of hospital mortality MECH-group
n = 51
BIO-group
n = 22
REIMPL-group
n = 22
All
n = 95
Heart failure (intraoperative), n (%) 2 (3.9) 2 (2.1)
Heart failure (postoperative), n (%) 4 (7.8) 1 (4.5) 5 (5.3)
Myocardial infarction, n (%) 1 (4.5) 1 (1.0)
Sepsis, n (%) 2 (3.9) 2 (2.1)
Stroke, n (%) 1 (2) 1 (4.5) 2 (2.1)
Σ hospital mortality, n (%) 9 (17.6) 3 (13.5) 0 12 (12.6)
Survival curve for the entire study population Figure 1
Survival curve for the entire study population.
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valve replacement. Only sparse data are available from the
literature dealing with the problem of ARR in septuage-
narians [8]. Ehrlich and co-workers described a hospital
mortality of 8.3% (7 of 84). This is comparable to the
5%–11.4% hospital mortality after aortic valve replace-
ment in the same age group [22-24].
In our study, two patients died intra-operatively, and
another 10 within the first 30 day or during hospital stay
(12/95 pts., 12.6%). Our institutional mortality for this
age group ranges from 8% for cardiac surgery up to 29%
in patients undergoing surgery for acute type A aortic dis-
section [25,26]. In other studies we revealed age and co-
morbidities as predictors for morbidity and mortality
[27,28]. We strongly believe that the mortality rate is
influenced by the amount of co-morbidities rather than
the surgical technique.
The standard approach to ARR is the use of composite
grafts with a mechanical prosthesis [29]. Composite con-
duits with stented bioprosthesis have shown reasonable
results [9,17]. Etz and associates recently published their
experience with 206 patients receiving custom made com-
posite conduits with a stented bioprosthesis (mean age 53
years) with a hospital mortality rate of 2.9% and a 10 year
survival rate of 89% [9]. Only a limited number of reports
compared mechanical and biological ARR [6,8]. Ehrlich
and co-workers showed that overall probability of survival
was similar for patients with composite grafts incorporat-
ing a mechanical or biological valve (mean age 73.9 years;
Survival curves for the sub groups Figure 2
Survival curves for the sub groups.
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n = 84) with a 5 year survival of approximately 60% in
both groups. Interestingly in this study survival was simi-
lar to that of an age-matched population. Byrne et al. com-
pared biological and mechanical root replacement in a
younger patient cohort with a median age of 53 years
respectively 54 years and could neither demonstrate a dif-
ference in hospital mortality (1.5% vs. 2.4%) nor in the 5
year survival rate (92.4% vs. 88.2%). However, in the bio-
logical root replacement group either aortic homografts or
stentless aortic valves were implanted.
In the present study, mean survival was 7 ± 1 years for the
entire cohort, with best results for patients in the REIMPL-
group (5-year survival rate 80%). The impact of pure aor-
tic insuffiency on results in this subgroup in controver-
sially discussed. A substantial number of patients
receiving a mechanical or biological composite graft had
either mixed AS/AI or AS only; in contrast patients sched-
uled for aortic root reimplantation had pure AI only. The
impact of different physiological subgroups (aortic regur-
gitation vs. aortic stenosis vs. stenosis/regurgitation) on
early and late outcome after aortic valve surgery is still dis-
cussed controversially. Scott and associates analysed
1,479 isolated aortic valve replacement procedures and
showed substantial differences in operative mortality rates
among physiological subgroups [30]. In contrast Nowicki
and colleagues reported on 5793 patients undergoing aor-
tic valve surgery and found no impact of valve diagnosis
on in-hospital mortality [31]. However, in both studies
no long-term results have been analysed.
For surgeons not familiar with valve sparing aortic root
procedures ARR with composite conduits is still a valuable
option. Whereas in this patient composite graft replace-
ment with stented bioprosthesis is omitting lifelong oral
anticoagulation und consequent avoidance of bleeding
complications [32].
Limitations
Patient's demographic and intraoperative data differed
significantly between groups in terms of number of previ-
ous cardiac operations, preoperative NYHA functional
class, and incidence of aortic arch replacement, all factors
that may reflect a selection bias for a certain operative
NYHA-Status of the patients pre- and postoperatively Figure 3
NYHA-Status of the patients pre- and postoperatively.
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technique. However, the multivariate analysis revealed
none of these factors as a predictor for hospital mortality.
Since this is a nonrandomised retrospective study cover-
ing the experience of 15 years, factors influencing the out-
come may have been missed and not analysed thus could
falsify the result of the multivariate analysis. However,
current factors that already proofed to have a potential
influence as predictors for hospital mortality and long-
term mortality have been proven.
Conclusion
The small number of patients in each group makes it dif-
ficult to draw definite conclusion about the impact of dif-
ferent surgical techniques for ARR on early and late
outcome.
However, our data indicate that valve sparing aortic root
Reimplantation is safe and effective in septuagenarians,
and is associated with low early and late morbidity and
mortality.
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